EA
NVRO

Emerald Acquisition’s NEVRO CORP. NVRO Stock Holding History

Emerald Acquisition’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$12.4M Buy
118,549
+24,331
+26% +$2.2M 0.02% 763
2016
Q2 		$6.95M Buy
+94,218
New +$6.39M 0.01% 1135

Other funds holding NVRO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Emerald Acquisition's NVRO Position: Q3 2016 in Review

Emerald Acquisition increased its NEVRO CORP. (NVRO) stake by 26% in Q3 2016, buying an estimated $2.2M and bringing the position to 118,549 shares worth $12.4M. The position accounts for 0.02% of the portfolio, ranked #763.

Emerald Acquisition first reported a position in NVRO in Q2 2016 and has held it in 2 quarters since. 192 funds tracked by Wall St. Rank hold NVRO as of Q3 2016.

  • Emerald Acquisition held 118,549 shares of NEVRO CORP. worth $12.4M as of Q3 2016.
  • Emerald Acquisition bought 24,331 NEVRO CORP. shares in Q3 2016, an estimated $2.2M.
  • NEVRO CORP. made up 0.02% of Emerald Acquisition's portfolio in Q3 2016, its #763 holding.
  • Emerald Acquisition first reported a position in NEVRO CORP. in Q2 2016 and has held it in 2 quarters since.
  • 192 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.